In vitro studies indicate that BPA potency for GPER is high, with biological effects measured in the low nanomolar range in breast cancer cells and breast cancer-associated fibroblasts (60, 94) and in human seminoma and testicular cancer cells (95). The gene discussed is GPER1; the disease is testicular cancer.